References: Kingella kingae native bone or joint infection:

  • Autmizguine J, Watt KM, Theoret Y, Kassir N, Laferriere C, Parent S, et al. Pharmacokinetics and pharmacodynamics of oral cephalexin in children with osteoarticular infections. Pediatr Infect Dis J 2013;32(12):1340-4. https://www.ncbi.nlm.nih.gov/pubmed/23811740
  • Gwee A, Autmizguine J, Curtis N, Duffull SB. Twice- and Thrice-daily Cephalexin Dosing for Staphylococcus aureus Infections in Children. Pediatr Infect Dis J 2020;39(6):519-22. https://www.ncbi.nlm.nih.gov/pubmed/32412727
  • Ramchandar N, Arnold J, Cannavino C, Bradley JS. Frequency of Dosing of Cephalexin for Oral Step-Down Therapy of Pediatric Osteoarticular Infections Caused by Methicillin-Sensitive Staphylococcus Aureus. Pediatr Infect Dis J 2020;39(6):523-5. https://www.ncbi.nlm.nih.gov/pubmed/32398570
  • Yu D, Bio LL. Shedding Light on Amoxicillin, Amoxicillin-clavulanate, and Cephalexin Dosing in Children from a Pharmacist's Perspective. J Pediatric Infect Dis Soc 2022;11(12):594-602. https://www.ncbi.nlm.nih.gov/pubmed/36112500